Exact Mass: 416.05975120000005
Exact Mass Matches: 416.05975120000005
Found 106 metabolites which its exact mass value is equals to given mass value 416.05975120000005,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
O-Carbamoyl-deacetylcephalosporin C
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
Trovafloxacin
Trovafloxacin (sold as Trovan by Pfizer) is a broad spectrum antibiotic that inhibits the uncoiling of supercoiled DNA in various bacteria by blocking the activity of DNA gyrase and topoisomerase IV. It was withdrawn from the market due to the risk of hepatotoxicity. It had better gram-positive bacterial coverage and less gram-negative coverage than the previous fluoroquinolones. [Wikipedia] J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors
Brocillin
C18H21N2O5S. K (416.08081960000004)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic Same as: D01649
5-[(4-{[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}-2-methylphenyl)methyl]-1,3-thiazolidine-2,4-dione
Fluorescein diacetate
D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins
Calomelanol D
mollicellin M
A member of the class of depsidones that is 3,4-dihydro-2H,7H-chromeno[7,6-b][1,4]benzodioxepine substituted by a chloro group at position 9, a hydroxy group at position 10, methyl groups at positions 2, 2, 5 and 8, a formyl group at position 11 and oxo groups at positions 4 and 7. Isolated from Chaetomium brasiliense it exhibits antimalarial and cytotoxic activities.
(E)-(1,8-dihydroxy-9,10-dioxo-9,10-dihydroanthracen-3-yl)-methyl 3-(4-hydroxyphenyl)acrylate|kniphofione B
CAY10597
EUK-134
dimethyl (2S,3aS,8bR)-4-(benzenesulfonyl)-1,2,3a,8b-tetrahydropyrrolo[2,3-b]indole-2,3-dicarboxylate
C20H20N2O6S (416.10420200000004)
N-PROPYL-3-METHYLPYRIDINIUM BIS(TRIFLUOROMETHYLSULFONYL)IMIDE
C11H14F6N2O4S2 (416.02991560000004)
2-[4-(Dimethylamino)styryl]-1-methylquinolinium iodide
Quinolinium,4-[2-[4-(dimethylamino)phenyl]ethenyl]-1-methyl-, iodide (1:1)
N-(6-Iodo-2-(trimethylsilyl)furo[3,2-b]pyridin-7-yl)pivalamide
C15H21IN2O2Si (416.04169959999996)
7-(6-bromohexoxy)-5-hydroxy-2-phenylchromen-4-one
C21H21BrO4 (416.06231260000004)
6-[[4-(2,5-Dihydro-2,5-Dioxo-1H-Pyrrol-1-Yl)Phenyl]Amino]-2-Naphthalenesulfonicacid Sodium Salt(1:1)
C20H13N2NaO5S (416.04428480000007)
Benzenesulfonamide,N,N-1,2-phenylenebis[4-methyl-
C20H20N2O4S2 (416.08644400000003)
3-METHYL-4-(5-NITRO-2-(PYRIDIN-2-YLTHIO)BENZYLIDENE)-1-PHENYL-1H-PYRAZOL-5(4H)-ONE
1-Butylpyridinium bis[(trifluoromethyl)sulfonyl]azanide
C11H14F6N2O4S2 (416.02991560000004)
2-(tert-butylcarbamoylamino)-N-(2-chloro-6-methylphenyl)-1,3-benzothiazole-6-carboxamide
C20H21ClN4O2S (416.10736760000003)
2,7,8-triamino-4-(3-bromo-4,5-dimethoxyphenyl)-4H-chromene-3-carbonitrile
C18H17BrN4O3 (416.04839519999996)
4,4-(9H-Fluorene-9,9-diyl)bis(2-chloroaniline)
C25H18Cl2N2 (416.08469679999996)
Quinacillin
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Ethyl 4-(2,8-dichloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinecarboxylate
C22H22Cl2N2O2 (416.10582519999997)
1-Hydroxy-2-anthraquinonyl beta-D-glucopyranosiduronic acid
tert-butyl 4-(4-ethyl-3-iodophenyl)-4-methyl-3-oxopentanoate
3-[5-(3-nitrobenzoyl)-1,3-dioxoisoindol-2-yl]benzoic acid
Ethylenediaminetetraacetic acid tetrasodium salt dihydrate
C10H16N2Na4O10 (416.03957160000004)
Benzenesulfonothioicacid, 4-methyl-, S1,S1-1,3-propanediyl ester
Crolibulin
C18H17BrN4O3 (416.04839519999996)
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent
(2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide
Floridin
2-[5-[(3,4-Dichlorophenyl)methylthio]-4-(2-furanylmethyl)-1,2,4-triazol-3-yl]pyridine
7-[[5-(4-Methoxyphenyl)-4-thieno[2,3-d]pyrimidinyl]oxy]-4-methyl-1-benzopyran-2-one
C23H16N2O4S (416.08307360000003)
2-[[3-(4-methylphenyl)-4-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]thio]-N-(2-thiazolyl)acetamide
2-[5-[(2,4-Dichlorophenyl)methylthio]-4-(2-furanylmethyl)-1,2,4-triazol-3-yl]pyridine
2-(benzenesulfonyl)-N-[4-(4-ethoxyphenyl)-5-methyl-1,3-thiazol-2-yl]acetamide
C20H20N2O4S2 (416.08644400000003)
propicillin potassium
C18H21KN2O5S (416.08081960000004)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
[(1R,2R,3S,4R,5R)-2,3,4-trihydroxy-5-(4-methyl-2-oxochromen-7-yl)oxycyclohexyl]methyl dihydrogen phosphate
C17H21O10P (416.08722960000006)
N-(2-furanylmethyl)-5-(4-methoxyphenyl)-7-(trifluoromethyl)-2-pyrazolo[1,5-a]pyrimidinecarboxamide
5-bromo-1-(1-oxopropyl)-N,N-dipropyl-2,3-dihydroindole-7-sulfonamide
4-[[2-[(4-Ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)thio]-1-oxoethyl]amino]benzoic acid ethyl ester
C19H20N4O3S2 (416.09767700000003)
N-[2-(2,4-dichlorophenyl)ethyl]-2-[[5-[1-(dimethylamino)propyl]-1,3,4-oxadiazol-2-yl]thio]acetamide
4-chloro-N-[3-(N-methylanilino)-1,4-dioxo-2-naphthalenyl]benzamide
C24H17ClN2O3 (416.09276420000003)
1-(1,3-Benzodioxol-5-yl)-3-[4-[(5-methyl-3-isoxazolyl)sulfamoyl]phenyl]urea
3-[4-(trifluoromethyl)phenyl]-N-[[2-(trifluoromethyl)phenyl]methyl]-4,5-dihydroisoxazole-5-carboxamide
1-[[4-(6-Fluoro-3-pyridinyl)phenyl]methyl]-5-(trifluoromethoxy)indole-2,3-dione
(E)-3-[1-(benzenesulfonyl)pyrrol-2-yl]-2-(4-fluorophenyl)sulfonylprop-2-enenitrile
6-(4-methoxyphenyl)-8-methyl-4-oxo-6H-pyrimido[2,1-b][1,3]thiazine-2,7-dicarboxylic acid O7-ethyl ester O2-methyl ester
C20H20N2O6S (416.10420200000004)
N-[5-[2-(4-chloroanilino)-4-thiazolyl]-4-methyl-2-thiazolyl]-2-furancarboxamide
4-[[2-[(2E)-2-[(Z)-2-chloro-3-(4-nitrophenyl)prop-2-enylidene]hydrazinyl]-2-oxoacetyl]amino]benzoic acid
C18H13ClN4O6 (416.05235880000004)
2-[(E)-3-oxo-3-phenylprop-1-enyl]sulfanyl-6-thiophen-2-yl-4-(trifluoromethyl)pyridine-3-carbonitrile
C20H11F3N2OS2 (416.02648719999996)
2-[5-[(Z)-(5,7-dimethyl-1-oxo-[1,3]thiazolo[3,2-a]benzimidazol-2-ylidene)methyl]furan-2-yl]benzoic acid
C23H16N2O4S (416.08307360000003)
3,4,5-Trihydroxy-6-[3-(6-hydroxy-7-methoxy-1,3-benzodioxol-5-yl)propanoyloxy]oxane-2-carboxylic acid
C17H20O12 (416.09547200000003)
5-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-3-hydroxy-4-sulooxycyclohexene-1-carboxylic acid
C16H16O11S (416.04133060000004)
2-[(3E)-3-[(5Z)-5-[(6-bromo-1H-indol-3-yl)methylidene]-3,6-dioxopiperazin-2-ylidene]propyl]guanidine
C17H17BrN6O2 (416.05962819999996)
Trovafloxacin
A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 6-amino-3-azabicyclo[3.1.0]hex-3-yl substituents at positions 1, 6 and 7 respectively. A broad-spectrum antibiotic that was withdrawn from the market due to risk of liver failure. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors
cefaloridine
A cephalosporin compound having pyridinium-1-ylmethyl and 2-thienylacetamido side-groups. A first-generation semisynthetic derivative of cephalosporin C.
BAY-1797
C20H17ClN2O4S (416.05975120000005)
BAY-1797 is a potent, orally active, and selective P2X4 antagonist, with an IC50 of 211 nM against human P2X4. BAY-1797 displays no or very weak activity on the other P2X ion channels. BAY-1797 shows anti-nociceptive and anti-inflammatory effects[1].
Thiamine monophosphate (chloride) (dihydrate)
C12H22ClN4O6PS (416.06861520000007)
Thiamine monophosphate chloride (dihydrate) is an endogenous metabolite.
(1r,4r,5r,6r,7s,8r)-6-(acetyloxy)-7-amino-4-hydroxy-4-(c-hydroxycarbonimidoyl)-8-(phosphonooxy)-9-oxa-3-thiabicyclo[3.3.1]nonane-1-carboxylic acid
C11H17N2O11PS (416.02906620000005)
6-(acetyloxy)-7-amino-4-hydroxy-4-(c-hydroxycarbonimidoyl)-8-(phosphonooxy)-9-oxa-3-thiabicyclo[3.3.1]nonane-1-carboxylic acid
C11H17N2O11PS (416.02906620000005)